Hikma Could Consider Exit Strategy For Generics Business

Also Provides Update On CEO Search As Recruitment Process Continues

Hikma says all options are on the table for its beleaguered generics business, with an immediate sale unlikely but the door open for a longer-term exit strategy. Meanwhile, the firm has also offered an update on recruitment for a new CEO.

Door Exit Dollar Sign Shadow
Hikma could consider exiting the generics business – but admits the timing might not be right to extract maximum value from the division • Source: Shutterstock

More from Strategy

More from Business